Navigation Links
Hispanics Respond Poorly to Standard Hepatitis C Therapy
Date:1/14/2009

They and blacks still share outcome disparities in treatment of liver disease, study says

WEDNESDAY, Jan. 14 (HealthDay News) -- The standard treatment for hepatitis C does not appear to help Hispanic whites with the liver disease as much as it helps non-Hispanic whites, a new study suggests.

This is second major ethnic group -- the other being blacks -- found not to respond well to the therapy, consisting of pegylated interferon with ribavirin, in recent years.

"Hispanics and African-Americans have a higher prevalence of hepatitis C than other groups, so it is imperative that we figure out what is behind the poor response rate, and continue to do clinical trials on new forms of therapies," study second author Dr. Lennox Jeffers, a professor of medicine at the University of Miami Miller School of Medicine, said in a news release issued by the university.

Jeffers served as principal investigator of the 2006 study that found blacks responded poorly to treatment for hepatitis C.

The new study, published in the Jan. 15 issue of The New England Journal of Medicine, looked at 269 Hispanic and 300 non-Hispanic white hepatitis C patients from across the country.

"This clearly tells us there may be factors that impact liver disease in Hispanics that we do not yet understand," senior author Dr. Paul Martin, chief of hepatology at the Miller School, said in the news release.

The researchers noted that the Hispanic population has been underrepresented in past hepatitis C studies, and more research into how the disease affects this ethnic group is necessary.

The hepatitis C virus, which is contracted through exposure to blood already tainted with the virus, can lead to liver cancer, liver failure or cirrhosis. Liver transplant can sometimes be the only option for survival.

Protease inhibitors, which are used in combination therapy to treat HIV, are being explored by some researchers as an additional treatment for hepatitis C.

More information

The U.S. Centers for Disease Control and Prevention has more about hepatitis C.



-- Kevin McKeever



SOURCE: University of Miami Miller School of Medicine, news release, Jan. 14, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
2. Mega Events in September Allow Heart Health Campaign to Reach Tens of Thousands of Hispanics During Cholesterol Awareness Month
3. U.S. Health Initiative Targets Aging Hispanics
4. Uncontrolled Blood Pressure Highest Among Hispanics, Prompting New Hypertension Project in San Antonio
5. Mega Events in September, Including Chicago Event This Sat./Sun., Allow Heart Health Campaign to Reach Tens of Thousands of Hispanics During Cholesterol Awareness Month
6. Hispanics hypertension better controlled with equal access to care
7. Many U.S. Hispanics Struggle With Health Care System
8. Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine
9. Latinos/Hispanics Across the Nation Recognize National Latino AIDS Awareness Day and Call to Action Leaders in Promoting HIV Testing, Prevention and Access to Care
10. New study questions disparities in vascular surgery among Hispanics
11. Blacks, Hispanics Live Longer With Alzheimers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hispanics Respond Poorly  to  Standard Hepatitis C Therapy
(Date:4/27/2017)... ... April 27, 2017 , ... Are you investing in the safety of your ... drownings during the summer. While most of us assume this type of accident will ... Very few people are taking the time to learn how to respond effectively or ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... announce the ATA 2017 President’s Awards recipients, comprised of organizations and individuals ... delivery. , The ATA 2017 President’s Awards recognize individuals and organizations ...
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may ... pelvic conditions and has helped many women become pregnant upon treating their diagnosis. ... office-based and simple outpatient evaluations. We can provide the necessary information to ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... ecosystem and domain expertise for sponsors and CROs to speed clinical development, ... management (RTSM) software platform. Bioclinica AGILE RTSM provides seamless clinical ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... awareness for Duchenne muscular dystrophy, and funding for Duchenne research, congratulates Capricor ... I/II HOPE clinical trial in Duchenne announced today. , Coalition Duchenne funded ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the highest market ... segment is likely to create absolute $ opportunity of a ... By the end of 2027, Cardiology Devices segment is projected ... expanding at a CAGR of 18.4% over the forecast period. ... reprocessed medical devices market in terms of revenue ...
(Date:4/19/2017)...  IRIDEX Corporation (Nasdaq: IRIX ) today ... first quarter 2017 after the close of trading on ... host a corresponding conference call beginning at 2:30 p.m. ... in listening to the conference call may do so ... 326-3030 for international callers, using conference ID: 92158987.  A ...
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
Breaking Medicine Technology: